Executive Director Bioanalysis
Bristol-Myers Squibb Company
Dr. Vibha Jawa is an Executive Director in Discovery and Translational Science at Bristol Myers Squibb, leading biotherapeutic and cell/gene therapy DMPK and bioanalysis while overseeing BMS’s developmental portfolio.
With 20+ years of experience in biologics, vaccines, and gene therapy, she has contributed to 20+ IND, BLA, and MAA filings. Previously, she worked at Merck, Amgen, and the University of Pennsylvania on gene therapy.
A recognized leader in bioanalysis and immunogenicity, Vibha has 100+ publications, including book chapters, and contributes to blogs and podcasts. She serves as a Reviewer and Associate Editor for The AAPS Journal and J. Pharm Sci, was named an AAPS Fellow in 2022, and is the Immediate Past Chair for Women in Pharmaceutical Sciences within AAPS. She also leads bioanalytical efforts in gene and cell therapy within GCTP and has chaired the Personalized Medicine Community.
Vibha leads the IQ Consortium for Cell/Viral/Gene Therapies, advises Europe’s Advanced Therapies Initiative, and mentors early-career scientists through AAPS, Women in Bio, LinkedIn, and other outreach groups. She is also President of STEAMpark’s Board of Trustees, supporting STEM education for low-income communities.